Pierre Dönnes

Vicore Pharma (Sweden) — Sweden

Immunology and Microbiology · Life Sciences

23h-index2.4kcitations64works9.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(16), Monoclonal and Polyclonal Antibodies Research(14), Systemic Lupus Erythematosus Research(11), vaccines and immunoinformatics approaches(10), T-cell and B-cell Immunology(9)

Publications64 total

Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
International Journal of Biological Macromolecules·2026Open Access
Serum metabolic signatures are associated with anti-drug antibody development in rheumatoid arthritis patients treated with adalimumab
2025Open Access
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T Cell proliferation and anti-tumor immunity in mice
Nature Communications·2024· 7 citedOpen Access
Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor
Cells·2024· 6 citedOpen Access
Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity
Clinical Immunology·2024· 3 citedOpen Access
The Combination of Vascular Endothelial Growth Factor A (VEGF-A) and Fibroblast Growth Factor 1 (FGF1) Modified mRNA Improves Wound Healing in Diabetic Mice: An Ex Vivo and In Vivo Investigation
Cells·2024· 41 citedOpen Access
Blood metabolomic and transcriptomic signatures stratify patient subgroups in multiple sclerosis according to disease severity
iScience·2024· 20 citedOpen Access
Patients with Multiple Sclerosis Who Develop Immunogenicity to Interferon-Beta Have Distinct Transcriptomic and Proteomic Signatures Prior to Treatment Which are Associated with Disease Severity
SSRN Electronic Journal·2024Open Access
Atherosclerosis Progression in the <scp>APPLE</scp> Trial Can Be Predicted in Young People With <scp>Juvenile‐Onset</scp> Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature
Arthritis & Rheumatology·2023· 18 citedOpen Access
Artificial intelligence in rheumatology
Elsevier eBooks·2023
List of contributors
Elsevier eBooks·2023
LB0004 Paediatric Systemic Lupus Erythematosus (pSLE) patient stratification and high-performance serum biomarkers identified responders to statin and patients with high cardiovascular risk in the APPLE trial (Atorvastatin for Atherosclerosis Progression in Paediatric Systemic Lupus Erythematosus)
Annals of the Rheumatic Diseases·2023Open Access
Abstract 2929: Modular peptide cargo delivery by targeting CD40 enables ligandome driven, precision immunotherapy via the Adaptable Drug Affinity Conjugate (ADAC™) technology
Cancer Research·2023· 1 cited
Relapsing Remitting and Secondary Progressive Multiple Sclerosis are Characterised by Distinct Metabolomic and Transcriptomic Signatures That Could Aid Patient Management Strategies
SSRN Electronic Journal·2023Open Access
Additional Analysis of the APPLE (Atherosclerosis Prevention in Paediatric Lupus Erythematosus) Trial Identifies Novel Determinants of Patient Heterogeneity and a Distinct Lipid Metabolomic Signature Associated with Atherosclerosis Progression
SSRN Electronic Journal·2023Open Access
Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis
Journal of Neuroimmunology·2022· 4 citedOpen Access
Long‐term SARS‐CoV‐2‐specific and cross‐reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
Immunity Inflammation and Disease·2022· 9 citedOpen Access
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
PLoS ONE·2021· 12 citedOpen Access
Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges
Frontiers in Pharmacology·2021· 131 citedOpen Access
Protein interaction, monocyte toxicity and immunogenic properties of cerium oxide crystals with 5% or 14% gadolinium, cobalt oxide and iron oxide nanoparticles – an interdisciplinary approach
Nanotoxicology·2021· 3 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Oliver Kohlbacher(15), Elizabeth C. Jury(13), Anna Fogdell‐Hahn(10), Florian Deisenhammer(9), Signe Hässler(8), Marc Pallardy(8), Philippe Broët(8), Junjie Peng(7), Leda Coelewij(7), Inès Pineda‐Torra(7), Petra Nytrová(7), Annette Höglund(6), Coziana Ciurtin(6), George Robinson(6), Delphine Bachelet(6), Cyprien Mbogning(6), Clemens Warnke(6), Sara M. Mangsbo(5), Naoimh Donnellan(5), Eva Havrdová(5)